<DOC>
	<DOCNO>NCT00620048</DOCNO>
	<brief_summary>The purpose study determine cell therapy cell ( autologous cell ) deliver catheter region heart poor blood flow safe improve ejection fraction heart failure symptom .</brief_summary>
	<brief_title>Stem Cell Study Subjects With Congestive Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Subjects 21 80 year old ( inclusive ) . Subjects functional class ( NYHA ) II III ischemic heart failure . Subjects attempt `` best '' cardiac medical therapy include longacting nitrate , maximal use betaadrenergic block agent , angiotensinconverting enzyme ( ACE ) inhibitor without control symptom . Subjects must identify noncandidate conventional revascularization refer cardiologist . Subjects must leave ventricular ejection fraction &lt; 40 % echocardiography . All subject must recent coronary angiogram ( within last 6 month ) document coronary anatomy insure presence coronary disease amenable standard revascularization procedure . Have serum Btype Natriuretic Peptide ( BNP ) level &gt; 100 pg/ml . Myocardial infarction ( Q wave nonQ wave define CKMB &gt; 3 time normal ) within 30 day treatment . Successful coronary revascularization procedure within 3 month study enrollment . Documented stroke transient ischemic attack ( TIA ) within 60 day study enrollment . NYHA Class IV heart failure patient idiopathic nonischemic heart failure . History severe aortic stenosis ( aortic valve area &lt; 1.0 cm2 ) insufficiency ( &gt; 2+ ) ; severe mitral stenosis ( mitral valve area &lt; 1.5 cm2 ) ; severe mitral insufficiency ( &gt; 2+ ) . Implantation biventricular pacemaker within 90 day study treatment . Severe comorbidity associate reduction life expectancy le 1 year , chronic medical illness ( i.e . severe chronic obstructive pulmonary disease , renal failure cancer ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>heart</keyword>
	<keyword>stem Cells</keyword>
	<keyword>low EF</keyword>
	<keyword>heart attack</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>congestive heart failure</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Low Ejection Fraction</keyword>
</DOC>